$MRNA: US IPO Weekly Recap: Biggest Biotech Breaks In 3-IPO Week

Date: Saturday, December 8th, 2018

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Moderna (NASDAQ:MRNA) was not the cure for the biotech industry, which has broadly sold off this quarter. Moderna upsized its offering to raise $604 million at …

Full article address: https://seekingalpha.com/article/4227190-u-s-ipo-weekly-recap-biggest-biotech-breaks-3-ipo-week

Related News:

$MRNA: Cambridge VC Flagship raises $824M for new life science investments

$YETI $MRNA $TME $DJI $SPX: Cramer Remix: You may get a better chance to buy this recent IPO

$MRNA: Moderna to Present at Upcoming Investor Conferences in March

$MRNA: Moderna to Report Fourth Quarter and Full Year 2018 Financial …

$MRNA $AZN: Moderna up 4% premarket on positive early-stage data supporting …

$MRNA: Phase 1 Data Published in Nature Communications Show Potential …

$MRNA: Is Moderna a Buy?

$FIT $AAPL $MRNA $TLRY $CGC $CRON: Fitbit, Moderna, Tilray: ‘Mad Money’ Lightning Round

$MRNA: Moderna reports early success in respiratory infection vaccine

$MRNA: Moderna Announces Positive Interim Phase 1 Data for First …

$MRNA: Moderna’s combo vaccine shows positive action in early-stage study …

Latest News:

$MA: Mastercard Invests $300 Million in Dubai Payments Firm

$WINMQ: Neiman Marcus, in Debt Talks, Makes It Easier to Bet It Will Fail

$TEX: Terex (TEX) Down 11.4% Since Last Earnings Report: Can It Rebound?

$ZNGA $MGM $LVS $BYD: Gaming Industry Outlook: Macau Volatility Continues to Hurt

$CAPL $CKH $AR $WTI: W&T Becomes the Highest Bidder on 15 Blocks in GoM Auction

$NGVT $GG $NEM $KL: Newmont Unveils Special Dividend, Gets Mexican Anti-Trust Nod

$WEX $CPRT $ADP $BAH: WEX Unveils Buyout Plan for EG Group’s Fuel Card Business

$MLI $LAWS $AIN $GWW: Reasons to Hold Grainger (GWW) in Your Portfolio for Now

$SKYW $FLY $UNP $AZUL: Union Pacific (UNP) Strong on Freight Revenues & Dividends

$PEN $VAR $MASI $SYK: Masimo Gets FDA Clearance for Rad-67 Monitoring Device

$LH: Should Value Investors Consider Laboratory Corporation (LH)?